$25m pumped into InSet
This article was originally published in Clinica
InSet Technologies, a Mount Olive, New Jersey-based developer of programmable, implantable drug pumps, has raised $25m in equity financing. The round was led by Clarus Ventures. InSet will use the funds to complete the regulatory approval process for its device, which delivers medication directly to the spinal cord to provide pain relief, and to build a sales infrastructure in anticipation of the product launch.